A carregar...

Recombinant human CD19L-sTRAIL effectively targets B cell precursor acute lymphoblastic leukemia

Patients with B cell precursor acute lymphoblastic leukemia (BPL) respond well to chemotherapy at initial diagnosis; however, therapeutic options are limited for individuals with BPL who relapse. Almost all BPL cells express CD19, and we recently cloned the gene encoding a natural ligand of the huma...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Invest
Main Authors: Uckun, Fatih M., Myers, Dorothea E., Qazi, Sanjive, Ozer, Zahide, Rose, Rebecca, D’Cruz, Osmond J., Ma, Hong
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Clinical Investigation 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4362237/
https://ncbi.nlm.nih.gov/pubmed/25621496
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI76610
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!